Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 12/02/25 | Sell | Chief Technology Officer | 3,104,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.23B | |
| +2.57% | -4.80% | +28.84% | +67.57% | 53.75B | |
| -0.11% | +0.86% | -15.63% | -13.56% | 23.48B | |
| -1.58% | -5.51% | -3.51% | +375.36% | 22B | |
| +2.33% | -1.02% | +20.19% | -12.24% | 19.78B | |
| +0.28% | -1.41% | +28.83% | -33.55% | 17.44B | |
| +0.33% | -6.07% | +16.06% | +539.05% | 14.66B | |
| +1.16% | +0.58% | +51.87% | +181.96% | 14.07B | |
| -5.09% | -10.87% | +153.11% | +272.20% | 13.02B | |
| Average | -0.06% | -1.55% | +34.10% | +161.99% | 25.94B | |
| Weighted average by Cap. | +0.27% | -0.44% | +27.70% | +125.22% |
Employees
6
